ELOXX PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events

On January 14, 2020, Eloxx Pharmaceuticals, Inc. issued a press release providing, among other things, an update of its phase 2 clinical trials of ELX-02 in cystic fibrosis and cystinosis, and its ERSG pipeline, as announced at Biotech ShowcaseÔ. A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits




Exhibit
  No.                     Description

  99.1       Press Release, dated January 14, 2020.

© Edgar Online, source Glimpses